This consensus document provides updated, individualized management flow charts for stable coronary artery disease, emphasizing both pharmacological and non-pharmacological interventions.
Informs individualized stable CAD management now; extends prior consensus with updated flow charts.
Stable coronary artery disease (CAD) is a clinical entity of great epidemiological importance. It is becoming increasingly common due to the longer life expectancy, being strictly related to age and to advances in diagnostic techniques and pharmacological and non-pharmacological interventions. Stable CAD encompasses a variety of clinical and anatomic presentations, making the identification of its clinical and anatomical features challenging. Therapeutic interventions should be defined on an individual basis according to the patient's risk profile. To this aim, management flow charts have been reviewed based on sustainability and appropriateness derived from recent evidence. Special emphasis has been placed on non-pharmacological interventions, stressing the importance of lifestyle changes, including smoking cessation, regular physical activity, and diet. Adherence to therapy as an emerging risk factor is also discussed.
No takes yet. Share an insight, caveat, or question.
Riccio et al. (2017) conducted a review in Stable coronary artery disease (CAD). Clinical management (pharmacological and non-pharmacological interventions) was evaluated. This consensus document reviews the clinical management of stable coronary artery disease, emphasizing individualized therapy, lifestyle modifications, and adherence to therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: